fc31 integrase is investigated as a novel tool for nonviral gene therapy as the enzyme can direct site-specific integration into a host chromosome. In order to investigate effects of fc31 integrase expression in normal human cells, we have generated stably transfected primary human fibroblasts expressing the enzyme. All control cells were cytogenetically normal, but in cells expressing fc31 integrase, numerous chromosomal abnormalities including various translocations were found, suggesting that the enzyme itself acts as a mutagen.
fc31 integrase, originally from Streptomyces lividans, is a recombinase with the potential to perform site-specific integration into a host chromosome. Normally, the enzyme mediates recombination between two different short sequences of DNA, the 39-bp phage attachment site attP and a 34-bp sequence of bacterial DNA, the bacterial attachment site attB. 1 In mouse and human genomes, fc31 integrase mediates the integration of plasmids bearing an attB site into sequences with partial sequence identity to attP (pseudo-attP sites). 2 Based on the identification of 101 integration sites in human cell lines, it was estimated that the total number of human pseudoattP sites is 370. 3 fc31 integrase-mediated gene delivery is under investigation for human gene therapy (reviewed by Ginsburg and Calos 4 ). In mice, fc31-mediated integration resulted in sustained and therapeutic levels of the coagulation factor IX. 5 In xenotransplantation models, fc31 integrase was used for correction of two inherited human skin diseases, junctional epidermolysis bullosa and recessive dystrophic epidermolysis bullosa. 6, 7 Finally, fc31-mediated gene delivery was used for the correction of murine hereditary tyrosinemia. 8 The safety of fc31 integrase-mediated integration has not been studied in great details. In the human 293 cell line, slightly imprecise integration into pseudo-attP sites were found resulting in microdeletions of 1-11 bp. 2 Ehrhardt et al. 9 found deletions up to 160 bp after integration into the chromosomal hot spot of integration in mouse liver, mpsL1. Held et al. 8 suggested that fc31 integrase may cause some level of chromosomal instability based on the dysplastic appearance of hepatocytes after integrase-mediated gene transfer into the liver of Fah À/À mice. Finally, Chalberg et al.
3 described deletions and rearrangements in human cell lines, but did not conclude whether these observations were a consequence of artifacts. These studies all used transient expression of fc31 integrase. We have studied effects of prolonged fc31 integrase expression in primary human fibroblasts. Primary embryonic fibroblasts were used owing to their high proliferative potential and genomic stability.
Primary human fibroblasts were transfected with the plasmids pBabepuro or pBabepuroatt, containing the attB sequence, with or without the plasmid pCMVInt, containing the fc31 integrase gene. The cotransfection experiments were performed with a 3:1 molar excess of pCMVInt compared to the pBabepuro/pBabepuroatt plasmids to increase the likelihood that pCMVInt plasmids were integrated in puromycin-resistant cells. After puromycin selection, DNA and RNA were isolated and analyzed using primers specific for integrase gene and also for the most commonly used integration site (the attP site A on chromosome 8). As seen in Figure 1 , fc31 integrase was able to direct the integration of a plasmid containing the attB recognition sequence into the previously characterized human genomic pseudo-attP site A (cA) on chromosome 8.
The karyotypes of transfected cells are shown in Table  1 and identified breakpoints in Table 2 . Cells transfected with pBabepuro or pBabepuroatt alone had normal karyotypes. In contrast, highly abnormal karyotypes were found in cells transfected with the pCMVInt plasmids ( Figure 2) . Five of the 14 identified breakpoints matched the localization of a published human pseudoattP site. 3 Analysis of puromycin-selected clones expressing the integrase likewise showed abnormal karyotypes. Thus, three out of nine clones from cells transfected with the integrase gene showed abnormal karyotypes in contrast to zero out of eight clones transfected with the control plasmids. The experiments were reproduced in primary human fibroblasts from another source (another embryo), and again, abnormal karyotypes were exclusively found in cells transfected with plasmids containing the fc31 integrase gene (data not shown).
Thus, we have shown that the fc31 integrase induces chromosome rearrangement in primary human cells raising serious safety concerns associated with unin- Tissue from the embryo (a foot) was minced, rinsed in phosphatebuffered saline (PBS) and incubated for 1 h in 4 ml of 0.1% trypsin/ ethylenediamnetetraacetic acid (EDTA) solution at 371C. After centrifugation, 4 ml collagenase solution was added and incubated at 371C for 1 h. Cells were cultivated in Dulbecco's modified Eagle's medium (Life Technologies Inc., Invitrogen, Taastrup, Denmark) supplemented with 10% fetal bovine serum (GIBCO, Invitrogen, Taastrup, Denmark) and 1% penicillin-streptomycin (GIBCO), analyzed and found to have a normal karyotype. The plasmid pBabepuro contains the puromycin selection marker driven by an SV40 promoter. The plasmid pBabepuroatt has the 285-bp attB sequence inserted into the SalI site in the polylinker. The plasmid pCMVInt contains the wild-type fc31 integrase gene under the control of the CMV promoter. Cells were transfected using FuGene 6 transfection reagent (Roche, Hvidoure, Denmark) at a ratio of 3 mg of FuGene 6 transfection reagent per mg of DNA. Negative control performed in each experiment included no DNA. One day after transfection, cells were subjected to puromycin selection (5 mg/ml). Genomic DNAs was analysed by polymerase chain reaction (PCR) using primers specific for the human pseudo-attP site A (cA) on chromosome 8 (forward primer: 5 0 -CGATGTAGGTCACGGTCTC GA-3 0 ; reverse primer: 5 0 -TTGCATGGCCTCATTTCCGTC-3 0 ) as described 2 and primers specific for the integrase gene (forward primer: 5 0 -ACTCGACCACTTCCCTTACC-3 0 ; reverse primer 5 0 -ACCACGCCTGAAGCTCATAC-3 0 ). RNA was analyzed as cDNA first using First Strand cDNA Synthesis Kit for reverse transcription-PCR (RT-PCR) (AMV) (Roche), and then analysed by PCR. Polymerase chain reaction products were analysed by electrophoresis on 1-2% agarose gels in tris-borate-EDTA (TBE) buffer stained with ethidium bromide. 
The basic normal karyotype is 46,XX, inv(9).
15 n: Number of karyotypes analyzed. a-e refer to the breakpoints described in Table 2 . Metaphase chromosomes were analyzed by standard Q-banding techniques 15-17 days after transfection. The description of chromosome aberrations was based on the recommendations of the International System for Human Cytogenetic Nomenclature (ISCN 1995) . 10 All cytogenetic analysis were performed in duplicate. a-e Refer to the breakpoints described in Table 1 .
Cytogenetic effects of /c31 integrase in primary human cells J Liu et al tended prolonged expression of the enzyme in a clinical setting. Another member of the family of site-specific recombinases, the Cre recombinase, has the ability to cause widespread DNA damage when expressed at high levels. 11 Here pseudosites were suspected to act as target for the integrase and give rise to a mutagenic background. As transgenic mice and Drosophila with fc31 integrase expression have been generated with no adverse consequences, [12] [13] [14] further work is required to understand the mechanisms behind fc31 integrasemediated chromosome instability. a b Figure 2 Representative abnormal karyotypes. (a) 46,XX,der(1)t(1;?), t(2;19)(q13;q13),inv(9)(p11q12) and (b) 46,XX,t(3;5;17)(q13;q31;p12),inv (9)(p11q12),t(10;15)(q21;q24).
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